Produced in partnership with Incyte, Cholangiocarcinoma Foundation and Target Cancer Foundation, the video is an invaluable resource to help patients understand their clinical trial …

This pilot phase I trial studies the side effects and best way to give sirolimus, gemcitabine hydrochloride, and cisplatin in treating patients at high risk for cholangiocarcinoma recurrence …

May 7, 2025 · This is a Phase 1/2, open-label, FIH study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDy), and antineoplastic activity of …

Jul 29, 2025 · Living with cholangiocarcinoma (bile duct cancer)? Connect with others like you for support and answers to your questions in the on Mayo Clinic Connect, a patient community.

Intrahepatic cholangiocarcinoma (ICC) is an aggressive biliary tract cancer (BTC) with distinct anatomic, molecular, and clinical characteristics that dis-tinguishes it from other BTCs.

This clinical trial is focused on studying a type of liver cancer known as intrahepatic cholangiocarcinoma, which is a cancer that occurs in the bile ducts inside the liver. The study …

5 days ago · Cholangiocarcinoma (CCA) is the second most common primary liver cancer after hepatocellular carcinoma (HCC), accounting for approximately 10–15% of all primary liver …

Feb 10, 2024 · This review summarizes the approach to resectable intrahepatic cholangiocarcinoma and reviews current evidence from clinical trials regarding systemic and …

Aug 22, 2024 · The goal of this observational cohort study is to assess the yield of preoperative endoscopic ultrasound focussed on lymph nodes in patients with presumed resectable …

Dec 23, 2022 · The goal of this observational cohort study is to assess the yield of preoperative endoscopic ultrasound focussed on lymph nodes in patients with presumed resectable …